// App-Quantinova.ai

: Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Researchers

Presenter

  • Florian Moik

Principal Investigators

  • Jakob Riedl

  • Dominik Barth

  • Wei-Shin Evelyn Chan

  • Sarah Wiedemann

  • Christoph Höller

  • Thorsten Fuereder

  • Philipp Jost

  • Ingrid Pabinger

  • Matthias Preusser

  • Cihan Ay

Medical Centers

  • Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria

  • Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, AUT

  • Department of Medicine I, Clinical Divison of Hematology and Hemostaseology, Medical University of Vienna, Vienna, AUT

  • Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria

  • Department of Dermatology, Medical University of Vienna, Vienna, Austria

Locations

  • Austria

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • C reactive protein

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved